Investors & Media - FoRx Therapeutics

Contact

About us
Science
Pipeline
Investors & Media
- Investors
- News & Events

About us
Science
Pipeline
Investors & Media
- Investors
- News & Events

FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers.

Company

Management Team

Board of Directors

Founders and Advisors

Investor Relations

Legal

© 2026 FoRx Therapeutics. All rights reserved.

About us
Science
Pipeline
Investors & Media
- Investors
- News & Events

© 2026 FoRx Therapeutics. All rights reserved.